ArticlePharmaceutics2025

Physiologically Based Pharmacokinetic Model of CYP2D6 Associated Interaction Between Venlafaxine and Strong Inhibitor Bupropion-The Influence of Age-Relevant Changes and Inhibitory Dose to Classify Therapeutical Success and Harm.

Ulrich Ruben Luecht et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.